Drug data last refreshed 1h ago · AI intelligence enriched 3w ago
Sodium Pertechnetate Tc 99m is a radioactive diagnostic agent used for nuclear medicine imaging procedures. It is administered via injection or oral routes as a solution to visualize organ function and blood flow. The drug works through gamma-ray emission, allowing real-time imaging of targeted tissues.
This diagnostic radiopharmaceutical is approaching loss of exclusivity with moderate competitive pressure (30/100), signaling potential workforce consolidation on the commercial team.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Sodium Pertechnetate Tc 99m offers limited career growth opportunity given the mature lifecycle and approaching loss of exclusivity with zero linked job postings. This role suits professionals seeking stable diagnostic imaging expertise in a legacy product environment, with emphasis on healthcare partnerships and operational efficiency.
Worked on SODIUM PERTECHNETATE TC 99M at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.